Lebenthal Global Advisors’s Boston Scientific BSX Stock Holding History

Lebenthal Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,807	Closed	-$1.37M	–	208
2026 Q1	$1.37M	Buy	21,807 +664	+3%	+$53.1K	0.2%	79
2025 Q4	$2.02M	Buy	21,143 +1,708	+9%	+$167K	0.31%	52
2025 Q3	$1.9M	Buy	19,435 +716	+4%	+$74.1K	0.33%	50
2025 Q2	$2.01M	Buy	18,719 +72	+0.4%	+$7.29K	0.38%	41
2025 Q1	$1.88M	Sell	18,647 -1,788	-9%	-$180K	0.35%	37
2024 Q4	$1.83M	Sell	20,435 -48	-0.2%	-$4.22K	0.33%	44
2024 Q3	$1.72M	Buy	20,483 +1,645	+9%	+$130K	0.35%	39
2024 Q2	$1.45M	Buy	18,838 +288	+2%	+$21.1K	0.32%	37
2024 Q1	$1.27M	Buy	18,550 +1,654	+10%	+$106K	0.28%	42
2023 Q4	$977K	Buy	+16,896	New	+$902K	0.23%	56

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lebenthal Global Advisors's BSX Position: Q2 2026 in Review

Lebenthal Global Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 21,807 shares — an estimated $1.37M sold.

Lebenthal Global Advisors first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $2.02M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Lebenthal Global Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Lebenthal Global Advisors sold 21,807 Boston Scientific shares in Q2 2026, an estimated $1.37M.
Lebenthal Global Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Lebenthal Global Advisors's Boston Scientific position peaked at $2.02M in Q4 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lebenthal Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.